Atrofia óptica ou atrofia ótica é a perda de algumas ou da maioria das fibras do nervo óptico. Na medicina, atrofia significa normalmente "encolhido mas capaz de recrescer ", assim alguns discutem que atrofia óptica como um termo patológico está um pouco errado, usando assim Neuropatia óptica.
Introdução
O que você precisa saber de cara
Doença rara caracterizada por perda visual progressiva (escotoma), ptose bilateral e fraqueza muscular. Pode apresentar miopatia mitocondrial, neuropatia axonal motora e sensorial, com alterações na transmissão neuromuscular e na retina. Associada a mutações em genes como FERMT3 e genes mitocondriais.
Tem tratamento?
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Entender a doença
Do básico ao detalhe, leia no seu ritmo
Preparando trilha educativa...
Sinais e sintomas
O que aparece no corpo e com que frequência cada sintoma acontece
Partes do corpo afetadas
+ 123 sintomas em outras categorias
Características mais comuns
Os sintomas variam de pessoa para pessoa. Abaixo estão as 359 características clínicas mais associadas, ordenadas por frequência.
Linha do tempo da pesquisa
Encontrou um erro ou informação desatualizada? Sugira uma correção →
Genética e causas
O que está alterado no DNA e como passa nas famílias
Genes associados
29 genes identificados com associação a esta condição.
Plays a central role in cell adhesion in hematopoietic cells (PubMed:19234463, PubMed:26359933). Acts by activating the integrin beta-1-3 (ITGB1, ITGB2 and ITGB3) (By similarity). Required for integrin-mediated platelet adhesion and leukocyte adhesion to endothelial cells (PubMed:19234460). Required for activation of integrin beta-2 (ITGB2) in polymorphonuclear granulocytes (PMNs) (By similarity) Isoform 2 may act as a repressor of NF-kappa-B and apoptosis
Cell projection, podosome
Leukocyte adhesion deficiency 3
A disorder characterized by recurrent bacterial infections without pus formation, leukocytosis and major bleeding disorders.
Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over t
Mitochondrion inner membrane
Leber hereditary optic neuropathy
A maternally inherited form of Leber hereditary optic neuropathy, a mitochondrial disease resulting in bilateral painless loss of central vision due to selective degeneration of the retinal ganglion cells and their axons. The disorder shows incomplete penetrance and male predominance. Cardiac conduction defects and neurological defects have also been described in some LHON patients. LHON results from primary mitochondrial DNA mutations affecting the respiratory chain complexes.
Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:15250827). Essential for the catalytic activity and assembly of complex I (PubMed:15250827)
Mitochondrion inner membrane
Leber hereditary optic neuropathy
A maternally inherited form of Leber hereditary optic neuropathy, a mitochondrial disease resulting in bilateral painless loss of central vision due to selective degeneration of the retinal ganglion cells and their axons. The disorder shows incomplete penetrance and male predominance. Cardiac conduction defects and neurological defects have also been described in some LHON patients. LHON results from primary mitochondrial DNA mutations affecting the respiratory chain complexes.
Component of the cytochrome c oxidase, the last enzyme in the mitochondrial electron transport chain which drives oxidative phosphorylation. The respiratory chain contains 3 multisubunit complexes succinate dehydrogenase (complex II, CII), ubiquinol-cytochrome c oxidoreductase (cytochrome b-c1 complex, complex III, CIII) and cytochrome c oxidase (complex IV, CIV), that cooperate to transfer electrons derived from NADH and succinate to molecular oxygen, creating an electrochemical gradient over t
Mitochondrion inner membrane
Leber hereditary optic neuropathy
A maternally inherited form of Leber hereditary optic neuropathy, a mitochondrial disease resulting in bilateral painless loss of central vision due to selective degeneration of the retinal ganglion cells and their axons. The disorder shows incomplete penetrance and male predominance. Cardiac conduction defects and neurological defects have also been described in some LHON patients. LHON results from primary mitochondrial DNA mutations affecting the respiratory chain complexes.
Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:28844695). Part of the enzyme membrane arm which is embedded in the lipid bilayer and involved in proton translocation (PubMed:28844695)
Mitochondrion inner membrane
Leber hereditary optic neuropathy
A maternally inherited form of Leber hereditary optic neuropathy, a mitochondrial disease resulting in bilateral painless loss of central vision due to selective degeneration of the retinal ganglion cells and their axons. The disorder shows incomplete penetrance and male predominance. Cardiac conduction defects and neurological defects have also been described in some LHON patients. LHON results from primary mitochondrial DNA mutations affecting the respiratory chain complexes.
Subunit a, of the mitochondrial membrane ATP synthase complex (F(1)F(0) ATP synthase or Complex V) that produces ATP from ADP in the presence of a proton gradient across the membrane which is generated by electron transport complexes of the respiratory chain (Probable). ATP synthase complex consist of a soluble F(1) head domain - the catalytic core - and a membrane F(1) domain - the membrane proton channel (PubMed:37244256). These two domains are linked by a central stalk rotating inside the F(1
Mitochondrion inner membrane
Neuropathy, ataxia, and retinitis pigmentosa
A syndrome characterized by variable combination of developmental delay, psychomotor retardation, hearing loss, optic atrophy and retinitis pigmentosa, dementia, seizures, ataxia, proximal neurogenic muscle weakness, and sensory neuropathy.
Component of the ubiquinol-cytochrome c reductase complex (complex III or cytochrome b-c1 complex) that is part of the mitochondrial respiratory chain. The b-c1 complex mediates electron transfer from ubiquinol to cytochrome c. Contributes to the generation of a proton gradient across the mitochondrial membrane that is then used for ATP synthesis
Mitochondrion inner membrane
Mitochondrial protein enriched in neurons that acts as a regulator of mitochondrial respiration (By similarity). Associates with the ATP synthase complex and facilitates ATP synthesis (By similarity). May be a chaperone protein involved in the turnover of the subunits of mitochondrial complex I N-module. It facilitates the degradation of N-module subunits damaged by oxidative stress, and contributes to complex I functional efficiency (PubMed:33465056)
Mitochondrion inner membrane
Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:14595656, PubMed:8644732). Essential for the catalytic activity and assembly of complex I (PubMed:14595656, PubMed:8644732)
Mitochondrion inner membrane
Leber hereditary optic neuropathy
A maternally inherited form of Leber hereditary optic neuropathy, a mitochondrial disease resulting in bilateral painless loss of central vision due to selective degeneration of the retinal ganglion cells and their axons. The disorder shows incomplete penetrance and male predominance. Cardiac conduction defects and neurological defects have also been described in some LHON patients. LHON results from primary mitochondrial DNA mutations affecting the respiratory chain complexes.
Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:22036843, PubMed:28031252, PubMed:30922174). Essential for the catalytic activity of complex I (PubMed:22036843, PubMed:30922174). Essential for the assembly of complex I (By similarity). Redox-sensitive, critical component of the oxygen-sensing pathway in the pulmonary vasculature w
Mitochondrion inner membrane
Mitochondrial complex I deficiency, nuclear type 6
A form of mitochondrial complex I deficiency, the most common biochemical signature of mitochondrial disorders, a group of highly heterogeneous conditions characterized by defective oxidative phosphorylation, which collectively affects 1 in 5-10000 live births. Clinical disorders have variable severity, ranging from lethal neonatal disease to adult-onset neurodegenerative disorders. Phenotypes include macrocephaly with progressive leukodystrophy, non-specific encephalopathy, cardiomyopathy, myopathy, liver disease, Leigh syndrome, Leber hereditary optic neuropathy, and some forms of Parkinson disease. MC1DN6 transmission pattern is consistent with autosomal recessive inheritance.
Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:1959619). Essential for the catalytic activity and assembly of complex I (PubMed:1959619, PubMed:26929434)
Mitochondrion inner membrane
Leber hereditary optic neuropathy
A maternally inherited form of Leber hereditary optic neuropathy, a mitochondrial disease resulting in bilateral painless loss of central vision due to selective degeneration of the retinal ganglion cells and their axons. The disorder shows incomplete penetrance and male predominance. Cardiac conduction defects and neurological defects have also been described in some LHON patients. LHON results from primary mitochondrial DNA mutations affecting the respiratory chain complexes.
Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:15250827, PubMed:8344246, PubMed:8644732). Essential for the catalytic activity and assembly of complex I (PubMed:15250827, PubMed:8344246, PubMed:8644732)
Mitochondrion inner membrane
Leber hereditary optic neuropathy
A maternally inherited form of Leber hereditary optic neuropathy, a mitochondrial disease resulting in bilateral painless loss of central vision due to selective degeneration of the retinal ganglion cells and their axons. The disorder shows incomplete penetrance and male predominance. Cardiac conduction defects and neurological defects have also been described in some LHON patients. LHON results from primary mitochondrial DNA mutations affecting the respiratory chain complexes.
Core subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I) which catalyzes electron transfer from NADH through the respiratory chain, using ubiquinone as an electron acceptor (PubMed:16996290). Essential for the catalytic activity and assembly of complex I (PubMed:16996290)
Mitochondrion inner membrane
Leber hereditary optic neuropathy
A maternally inherited form of Leber hereditary optic neuropathy, a mitochondrial disease resulting in bilateral painless loss of central vision due to selective degeneration of the retinal ganglion cells and their axons. The disorder shows incomplete penetrance and male predominance. Cardiac conduction defects and neurological defects have also been described in some LHON patients. LHON results from primary mitochondrial DNA mutations affecting the respiratory chain complexes.
Sodium-independent anion exchanger which mediates the electroneutral exchange of chloride for bicarbonate ions across the cell membrane (PubMed:15184086, PubMed:34668226). Plays an important role in osteoclast differentiation and function (PubMed:34668226). Regulates bone resorption and calpain-dependent actin cytoskeleton organization in osteoclasts via anion exchange-dependent control of pH (By similarity). Essential for intracellular pH regulation in CD8(+) T-cells upon CD3 stimulation, modul
Apical cell membraneBasolateral cell membrane
Osteopetrosis, autosomal recessive 9
A form of osteopetrosis, a rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. Osteopetrosis occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. Recessive osteopetrosis commonly manifests in early infancy with macrocephaly, feeding difficulties, evolving blindness and deafness, bone marrow failure, severe anemia, and hepatosplenomegaly. Deafness and blindness are generally thought to represent effects of pressure on nerves. OPTB9 is characterized by increased bone density and bone fragility, as well as renal failure.
Acts as a multivalent adapter protein that regulates Rab7-dependent and HOPS complex-dependent fusion events in the endolysosomal system and couples autophagic and the endocytic trafficking pathways. Acts as a dual effector of RAB7A and ARL8B that simultaneously binds these GTPases, bringing about clustering and fusion of late endosomes and lysosomes (PubMed:25498145, PubMed:28325809). Required for late stages of endolysosomal maturation, facilitating both endocytosis-mediated degradation of gro
Autolysosome membraneEndosome membraneLate endosome membraneLysosome membrane
Osteopetrosis, autosomal recessive 6
A rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. Osteopetrosis occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. Recessive osteopetrosis commonly manifests in early infancy with macrocephaly, feeding difficulties, evolving blindness and deafness, bone marrow failure, severe anemia, and hepatosplenomegaly. Deafness and blindness are generally thought to represent effects of pressure on nerves.
This is the catalytic component of the active enzyme, which catalyzes the hydrolysis of ATP coupled with the exchange of sodium and potassium ions across the plasma membrane. This action creates the electrochemical gradient of sodium and potassium ions, providing the energy for active transport of various nutrients
Cell membrane
Dystonia 12
An autosomal dominant dystonia-parkinsonism disorder. Dystonia is defined by the presence of sustained involuntary muscle contractions, often leading to abnormal postures. DYT12 patients develop dystonia and parkinsonism between 15 and 45 years of age. The disease is characterized by an unusually rapid evolution of signs and symptoms. The sudden onset of symptoms over hours to a few weeks, often associated with physical or emotional stress, suggests a trigger initiating a nervous system insult resulting in permanent neurologic disability.
May play some role in mitochondrial processes
Mitochondrion
3-methylglutaconic aciduria 3
An autosomal recessive metabolic disorder that causes a neuro-ophthalmologic syndrome consisting of early-onset bilateral optic atrophy, spasticity, extrapyramidal dysfunction and cognitive deficit. Urinary excretion of 3-methylglutaconic acid and 3-methylglutaric acid is increased. MGCA3 can be distinguished from MGCA1 by the absence of increase of 3-hydroxyisovaleric acid levels.
Receptor for TNFSF11/RANKL/TRANCE/OPGL; essential for RANKL-mediated osteoclastogenesis (PubMed:9878548). Its interaction with EEIG1 promotes osteoclastogenesis via facilitating the transcription of NFATC1 and activation of PLCG2 (By similarity). Involved in the regulation of interactions between T-cells and dendritic cells (By similarity)
Cell membraneMembrane raft
Familial expansile osteolysis
Rare autosomal dominant bone disorder characterized by focal areas of increased bone remodeling. The osteolytic lesions develop usually in the long bones during early adulthood. FEO is often associated with early-onset deafness and loss of dentition.
Dynamin-related GTPase that is essential for normal mitochondrial morphology by mediating fusion of the mitochondrial inner membranes, regulating cristae morphology and maintaining respiratory chain function (PubMed:16778770, PubMed:17709429, PubMed:20185555, PubMed:24616225, PubMed:28628083, PubMed:28746876, PubMed:31922487, PubMed:32228866, PubMed:32567732, PubMed:33130824, PubMed:33237841, PubMed:37612504, PubMed:37612506). Exists in two forms: the transmembrane, long form (Dynamin-like GTPas
Mitochondrion inner membraneMitochondrion intermembrane space
Optic atrophy 1
A condition that features progressive visual loss in association with optic atrophy. Atrophy of the optic disk indicates a deficiency in the number of nerve fibers which arise in the retina and converge to form the optic disk, optic nerve, optic chiasm and optic tracts. OPA1 is characterized by an insidious onset of visual impairment in early childhood with moderate to severe loss of visual acuity, temporal optic disk pallor, color vision deficits, and centrocecal scotoma of variable density.
Required for osteoclast and melanocyte maturation and function
Lysosome membrane
Osteopetrosis, autosomal recessive 5
A rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. Osteopetrosis occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. Recessive osteopetrosis commonly manifests in early infancy with macrocephaly, feeding difficulties, evolving blindness and deafness, bone marrow failure, severe anemia, and hepatosplenomegaly. Deafness and blindness are generally thought to represent effects of pressure on nerves. OPTB5 patients manifest primary central nervous system involvement in addition to the classical stigmata of severe bone sclerosis, growth failure, anemia, thrombocytopenia and visual impairment with optic atrophy.
Catalyzes the reversible hydration of carbon dioxide (PubMed:11327835, PubMed:11802772, PubMed:11831900, PubMed:12056894, PubMed:12171926, PubMed:1336460, PubMed:14736236, PubMed:15300855, PubMed:15453828, PubMed:15667203, PubMed:15865431, PubMed:16106378, PubMed:16214338, PubMed:16290146, PubMed:16686544, PubMed:16759856, PubMed:16807956, PubMed:17127057, PubMed:17251017, PubMed:17314045, PubMed:17330962, PubMed:17346964, PubMed:17540563, PubMed:17588751, PubMed:17705204, PubMed:18024029, PubMe
CytoplasmCell membrane
Osteopetrosis, autosomal recessive 3
A rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. Osteopetrosis occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. Recessive osteopetrosis commonly manifests in early infancy with macrocephaly, feeding difficulties, evolving blindness and deafness, bone marrow failure, severe anemia, and hepatosplenomegaly. Deafness and blindness are generally thought to represent effects of pressure on nerves. OPTB3 is associated with renal tubular acidosis, cerebral calcification (marble brain disease) and in some cases with intellectual disability.
Cytokine that binds to TNFRSF11B/OPG and to TNFRSF11A/RANK. Osteoclast differentiation and activation factor. Augments the ability of dendritic cells to stimulate naive T-cell proliferation. May be an important regulator of interactions between T-cells and dendritic cells and may play a role in the regulation of the T-cell-dependent immune response. May also play an important role in enhanced bone-resorption in humoral hypercalcemia of malignancy (PubMed:22664871). Induces osteoclastogenesis by
Cell membraneCytoplasmSecreted
Osteopetrosis, autosomal recessive 2
A rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. Osteopetrosis occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. Recessive osteopetrosis commonly manifests in early infancy with macrocephaly, feeding difficulties, evolving blindness and deafness, bone marrow failure, severe anemia, and hepatosplenomegaly. Deafness and blindness are generally thought to represent effects of pressure on nerves. OPTB2 is characterized by paucity of osteoclasts, suggesting a molecular defect in osteoclast development.
Functions in mitochondrial and peroxisomal division (PubMed:11514614, PubMed:12499366, PubMed:17301055, PubMed:17460227, PubMed:17553808, PubMed:18695047, PubMed:18838687, PubMed:19342591, PubMed:19411255, PubMed:19638400, PubMed:23283981, PubMed:23530241, PubMed:23921378, PubMed:26992161, PubMed:27145208, PubMed:27145933, PubMed:27301544, PubMed:27328748, PubMed:29478834, PubMed:32439975, PubMed:32484300, PubMed:9570752, PubMed:9786947). Mediates membrane fission through oligomerization into me
Cytoplasm, cytosolGolgi apparatusEndomembrane systemMitochondrion outer membranePeroxisomeMembrane, clathrin-coated pitCytoplasmic vesicle, secretory vesicle, synaptic vesicle membrane
Electrogenic sodium-dependent amino acid transporter with a preference for L-glutamine, L-alanine, L-histidine, L-aspartate and L-arginine. May facilitate glutamine uptake in both excitatory and inhibitory neurons. The transport mechanism and stoichiometry remain to be elucidated
MembraneCytoplasm, cell cortexCell projection, axon
Foveal hypoplasia 2
An isolated form of foveal hypoplasia, a developmental defect of the eye defined as the lack of foveal depression with continuity of all neurosensory retinal layers in the presumed foveal area. Clinical features include absence of foveal pit on optical coherence tomography, absence of foveal hyperpigmentation, absence of foveal avascularity, absence of foveal and macular reflexes, decreased visual acuity, and nystagmus. Optic nerve misrouting and anterior segment dysgenesis are observed in some FVH2 patients.
Serine/threonine-protein kinase that detects bacterial pathogen-associated molecular pattern metabolites (PAMPs) and initiates an innate immune response, a critical step for pathogen elimination and engagement of adaptive immunity (PubMed:28222186, PubMed:28877472, PubMed:30111836). Specifically recognizes and binds ADP-D-glycero-beta-D-manno-heptose (ADP-Heptose), a potent PAMP present in all Gram-negative and some Gram-positive bacteria (PubMed:30111836). ADP-Heptose-binding stimulates its kin
Cytoplasm, cytosolCytoplasm, cytoskeleton, spindle poleCytoplasm, cytoskeleton, microtubule organizing center, centrosomeCell projection, cilium
Retinal dystrophy, optic nerve edema, splenomegaly, anhidrosis, and migraine headache syndrome
An autosomal dominant disorder characterized by decreased vision associated with optic nerve edema, evident in childhood. Low-grade ocular inflammation is common in affected individuals. Later in childhood or the second decade of life, patients have increasing visual impairment, abnormal cone function and loss of rod function. By the third decade of life, visual acuity ranges from counting fingers to no light perception. Patients also show anhidrosis, splenomegaly, mild pancytopenia, and most experience headaches that may be migraine-like in nature.
Slowly voltage-gated channel mediating the exchange of chloride ions against protons (PubMed:18449189, PubMed:21527911). Functions as antiporter and contributes to the acidification of the lysosome lumen and may be involved in maintaining lysosomal pH (PubMed:18449189, PubMed:21527911, PubMed:31155284). The CLC channel family contains both chloride channels and proton-coupled anion transporters that exchange chloride or another anion for protons (By similarity). The presence of conserved gating
Lysosome membrane
Osteopetrosis, autosomal recessive 4
A rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. Osteopetrosis occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. Recessive osteopetrosis commonly manifests in early infancy with macrocephaly, feeding difficulties, evolving blindness and deafness, bone marrow failure, severe anemia, and hepatosplenomegaly. Deafness and blindness are generally thought to represent effects of pressure on nerves.
Subunit of the V0 complex of vacuolar(H+)-ATPase (V-ATPase), a multisubunit enzyme composed of a peripheral complex (V1) that hydrolyzes ATP and a membrane integral complex (V0) that translocates protons (By similarity). V-ATPase is responsible for acidifying and maintaining the pH of intracellular compartments and in some cell types, is targeted to the plasma membrane, where it is responsible for acidifying the extracellular environment (By similarity). Seems to be directly involved in T-cell a
Membrane
Osteopetrosis, autosomal recessive 1
A rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. Osteopetrosis occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. Recessive osteopetrosis commonly manifests in early infancy with macrocephaly, feeding difficulties, evolving blindness and deafness, bone marrow failure, severe anemia, and hepatosplenomegaly. Deafness and blindness are generally thought to represent effects of pressure on nerves.
Transcription factor with important functions in the development of the eye, nose, central nervous system and pancreas. Required for the differentiation of pancreatic islet alpha cells (By similarity). Competes with PAX4 in binding to a common element in the glucagon, insulin and somatostatin promoters. Regulates specification of the ventral neuron subtypes by establishing the correct progenitor domains (By similarity). Acts as a transcriptional repressor of NFATC1-mediated gene expression (By s
Nucleus
Aniridia 1
A congenital, bilateral, panocular disorder characterized by complete absence of the iris or extreme iris hypoplasia. Aniridia is not just an isolated defect in iris development but it is associated with macular and optic nerve hypoplasia, cataract, corneal changes, nystagmus. Visual acuity is generally low but is unrelated to the degree of iris hypoplasia. Glaucoma is a secondary problem causing additional visual loss over time.
Probable phosphoinositide-binding protein involved in protein sorting and membrane trafficking in endosomes. Plays a role in cilium biogenesis through regulation of the transport and the localization of proteins to the cilium. Required for the localization to the cilium of V-ATPase subunit ATP6V1D and ATP6V0D1, and RAB8A. Involved in osteoclast differentiation and therefore bone resorption
CytoplasmEndosome membraneCytoplasm, cytoskeleton, microtubule organizing center, centrosome
Osteopetrosis, autosomal recessive 8
A rare genetic disease characterized by abnormally dense bone, due to defective resorption of immature bone. Osteopetrosis occurs in two forms: a severe autosomal recessive form occurring in utero, infancy, or childhood, and a benign autosomal dominant form occurring in adolescence or adulthood. Recessive osteopetrosis commonly manifests in early infancy with macrocephaly, feeding difficulties, evolving blindness and deafness, bone marrow failure, severe anemia, and hepatosplenomegaly. Deafness and blindness are generally thought to represent effects of pressure on nerves. OPTB8 is clinically characterized by dense bones with no distinction between outer and inner plates, due to extensive encroachment of cortical bone into the medullary space, increased head circumference, broad open fontanelle, frontal bossing, and hepatosplenomegaly. Osteoclasts number is low and their bone resorptive capacity is impaired.
Variantes genéticas (ClinVar)
138 variantes patogênicas registradas no ClinVar.
Classificação de variantes (ClinVar)
Distribuição de 15 variantes classificadas pelo ClinVar.
Vias biológicas (Reactome)
39 vias biológicas associadas aos genes desta condição.
Diagnóstico
Os sinais que médicos procuram e os exames que confirmam
Tratamento e manejo
Remédios, cuidados de apoio e o que precisa acompanhar
Onde tratar no SUS
Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)
🇧🇷 Atendimento SUS — Neuropatia óptica hereditária
Selecione um estado ou use sua localização para ver resultados.
Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.
Pesquisa ativa
Ensaios clínicos abertos e novidades científicas recentes
Ensaios em destaque
🟢 Recrutando agora
6 pesquisas recrutando participantes. Converse com seu médico sobre a possibilidade de participar.
Outros ensaios clínicos
41 ensaios clínicos encontrados, 10 ativos.
Publicações mais relevantes
Mostrando amostra de 200 publicações de um total de 1.009
Disrupted energy metabolism is associated with retinal ganglion cell degeneration in autosomal dominant optic atrophy.
Autosomal dominant optic atrophy (ADOA) is a hereditary optic neuropathy caused by OPA1 variants, leading to retinal ganglion cell (RGC) degeneration and vision loss. The mechanisms behind RGC vulnerability to mitochondrial dysfunction remain unclear. We developed a patient-specific Opa1V291D/+ knock-in mouse model to investigate mitochondrial dysfunction and retinal metabolism in ADOA. We observed that Opa1V291D/+ mice exhibited anatomical and functional RGC abnormalities recapitulating the ADOA phenotypes. Reduced optic atrophy 1 (OPA1) protein levels were noted in Opa1V291D/+ mice, accompanied by decreased protein stability. Moreover, mitochondrial function was compromised, as indicated by reduced Complex I activity, increased oxidative stress, and diminished adenosine triphosphate production in the retinas of Opa1V291D/+ mice. Spatial metabolomics revealed energy deficits in the inner retina and heightened glycolysis in the outer retina. Immunostaining showed decreased expression of glycolytic proteins in the ganglion cell layer. Single-nucleus RNA sequencing disclosed significant down-regulation of energy-production genes in RGCs, while other retinal cell types remained unaffected. These findings emphasize the specific vulnerability of RGCs to bioenergetic crises, connecting disrupted energy homeostasis to their degeneration. By increasing the nicotinamide adenine dinucleotide (NAD+)/reduced form of NAD+ (NADH) redox ratio through the overexpression of mitochondrial-targeted Lactobacillus brevis NADH oxidase (MitoLbNOX) in RGCs, we demonstrated improved RGC function and survival through enhanced energy metabolism and reduced oxidative stress. These findings confirm that disrupted energy metabolism leads to RGC degeneration and emphasize the enhancement of the NAD+/NADH redox ratio as a promising treatment strategy to protect RGCs from degeneration in ADOA.
Pharmacological Depletion of Retinal Mononuclear Phagocytes Is Neuroprotective in a Mouse Model of Mitochondrial Optic Neuropathy.
The Vglut2-Cre;ndufs4loxP/loxP mouse strain with retinal ganglion cell (RGC)-specific mitochondrial complex I dysfunction develops severe RGC degeneration by postnatal day 90 (P90), with accompanying retinal mononuclear phagocyte (MNP) accumulation. We have reported that continuous exposure to hypoxia partially rescues RGC death in these mice, with minimal effect on MNP abundance. We hypothesized that pharmacological depletion of MNPs with the colony-stimulating factor-1 receptor inhibitor pexidartinib would enhance RGC neuroprotection by hypoxia. Iba1+ retinal MNP depletion was assessed in C57Bl/6J mice fed control or pexidartinib-infused chow beginning at P25. Subsequently, Vglut2-Cre;ndufs4loxP/loxP mice and control littermates were raised under normoxia or hypoxia and fed control or pexidartinib chow from P25 to P90. The neuroprotective effect of pexidartinib and hypoxia alone and in combination was assessed by quantifying RGC soma and axon survival in retinal flat mounts and optic nerve cross-sections. Pexidartinib completely depleted retinal MNPs within 1 week of treatment. Untreated Vglut2-Cre;ndufs4loxP/loxP mice exhibited the expected approximately 50% reduction of RGC soma and axon survival at P90 (P < 0.0001 for both). Hypoxia or pexidartinib monotherapy each reduced RGC degeneration by more than one-half, whereas their combination resulted in complete RGC neuroprotection (P < 0.01 for all 3 treatments). Normal myelination patterns were restored in mice receiving dual therapy. Pexidartinib effectively depletes retinal MNPs and is neuroprotective in the setting of severe RGC mitochondrial dysfunction. This therapeutic effect is additive to that of hypoxia. Combating retinal neuro-inflammation may therefore be a useful adjunct therapy in mitochondrial optic neuropathies like Leber hereditary optic neuropathy (LHON).
Atypical clinical and MRI features in Leber hereditary optic neuropathy: a case series of four patients.
Leber's hereditary optic neuropathy (LHON) is a mitochondrial disorder typically presenting with subacute, painless, bilateral vision loss in young individuals. While often recognizable, atypical presentations can complicate diagnosis. Notably, optic nerve lesions on MRI are uncommon in LHON and are typically associated with inflammatory optic neuropathies, increasing the risk of misdiagnosis. We retrospectively analyzed four patients who initially presented with suspected optic neuritis but were later diagnosed with LHON. Demographic, genetic, clinical, and multimodal data were retrieved from medical records. The series included two adolescent males, a 51-year-old man, and a 52-year-old woman. All experienced subacute, bilateral vision loss and were later found to carry pathogenic LHON mutations. However, their initial presentations were misleading. The two adult patients presented beyond the typical age of onset; one was initially diagnosed with glaucoma due to increased intraocular pressure, while the other had a history of Fahr's syndrome. One adolescent reported ocular pain with eye movements and showed a relative afferent pupillary defect, mimicking optic neuritis. Two patients lacked typical fundoscopic findings suggestive of LHON. MRI findings further complicated the diagnosis: all patients showed T2-FLAIR hyperintensities of the optic nerves with contrast enhancement, and in three cases abnormalities extended posteriorly to the chiasm and optic tracts on follow-up MRI. MRI abnormalities involving the optic pathway do not exclude LHON and may be present in atypical cases. LHON should be considered in all patients presenting with bilateral subacute visual loss, even when clinical or imaging features suggest alternative diagnoses.
Modifier variants in metabolic pathways are associated with an increased penetrance of Leber's Hereditary Optic Neuropathy.
Leber's hereditary optic neuropathy (LHON) is a debilitating mitochondrial disease characterised by bilateral painless vision loss. Despite being the most prevalent mitochondrial disorder, the precise pathophysiological mechanisms underlying the penetrance of LHON remain poorly understood. Nuclear modifier genes have been long suspected to affect phenotype-severity, however, specific cellular pathways implicated in the disease penetrance have been only suggested recently. In recent years, autosomal recessive variants in nuclear genes involved in complex I function and metabolic pathways were recognised to cause a typical LHON phenotype. This was proposed as a new autosomal recessive disease mechanism for LHON (arLHON). The association between nuclear variants and the LHON phenotype makes the nuclear pathways disrupted in arLHON the strongest candidates to act as modifiers of mitochondrial LHON (mLHON). In this study we systematically investigated a large cohort of 23 symptomatic and 28 asymptomatic individuals carrying one of the three primary mitochondrial LHON variants. We identified several heterozygous pathogenic nuclear variants amongst the affected individuals that were consistently linked to metabolic and complex I related pathways, mirroring those disrupted in arLHON. Our findings are consistent with the presence of a second hit in specific biological pathways impairing ATP production. We propose that in addition to the primary mitochondrial variants, disruption in these nuclear-encoded pathways drives the clinical manifestation of LHON. Genes involved in the same pathways also emerge as exciting candidates for future association with arLHON. The present study deepens our understanding of LHON's pathophysiology and provides a new framework for identifying novel disease-modifying targets.
A multistage cost-effective strategy for the molecular diagnosis of unexplained vision loss patients: practice in inherited ocular fundus disease.
Inherited ocular fundus diseases are the most common causes of blindness with high heterogeneity. We established a tiered strategy for the molecular diagnosis of unexplained vision loss patients. Patients were screened with ophthalmological examinations followed by a tiered genetic diagnosis, including mitochondrial genome sequencing, multigene panel and whole exome sequencing. A total of 146 individuals with unexplained vision loss were enrolled, including 103 individuals with abnormal pattern visual evoked potential and 43 individuals with abnormal optic coherence tomography. Based on our tiered strategy for molecular diagnosis, 33 cases were diagnosed with Leber's hereditary optic neuropathy, with common or very rare mitochondrial variants. Moreover, 22 cases with monogenic disorders were diagnosed with 15 novel and 16 reported mutations. Our study reveals the genetic etiology of unexplained vision loss and expands the genetic variation spectrum. The tiered cost-effective strategy for molecular diagnosis improves genetic detection rates and is expected to be applied to future clinical practice.
Publicações recentes
Leber Hereditary Optic Neuropathy in the Elderly: A Case Report.
Optimized ND4 allotopic expression for gene therapy of Leber's hereditary optic neuropathy.
Leber hereditary optic neuropathy triggered by the AstraZeneca coronavirus disease 2019 vaccination.
Impact of individualized colored spectacle filters on photophobia and visual comfort in central visual field defect patients: a one-year study.
Chronic Progressive External Ophthalmoplegia Associated With the m.14484T>C Leber Hereditary Optic Neuropathy Mutation.
📚 EuropePMC1.356 artigos no totalmostrando 197
Chronic Progressive External Ophthalmoplegia Associated With the m.14484T>C Leber Hereditary Optic Neuropathy Mutation.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology SocietyA multistage cost-effective strategy for the molecular diagnosis of unexplained vision loss patients: practice in inherited ocular fundus disease.
Molecular genetics and genomics : MGGIntegrated molecular and clinical profiling of primary mitochondrial oxidative phosphorylation disorders in an Indian cohort: Insights from genetics, neuroimaging, and machine learning.
MitochondrionA Case Report of Late-Onset Leber's Hereditary Optic Neuropathy Diagnosed Following Vision Loss After Cataract Surgery.
Neuro-ophthalmology (Aeolus Press)Visual Loss from Leber's Optic Neuropathy Presenting in a 76-Year-Old Man with the 14484 Mutations.
Neuro-ophthalmology (Aeolus Press)Five-year post-onset visual acuity trajectories in Japanese Leber hereditary optic neuropathy: a longitudinal analysis by age, sex, and mtDNA mutation.
Canadian journal of ophthalmology. Journal canadien d'ophtalmologieLeber Hereditary Optic Neuropathy Caused by the Rare MT-ND1 m.3394T>C Mutation: A Case With Favorable Visual Prognosis and a Literature Review.
CureusA Heteroplasmic MT-CO2 m.8024G > A Variant Is Associated with Mitochondrial Bioenergetic Deficiency and Optic Atrophy.
Molecular neurobiologyMesenchymal stem cell mitochondrial transfer effectively protects Leber's Hereditary Optic Neuropathy (LHON) mutant cells from mitochondrial damage.
Acta histochemicaOxidative stress imbalance and cellular damage mediated by the ND4 G11778A mutation.
Scientific reportsDisrupted energy metabolism is associated with retinal ganglion cell degeneration in autosomal dominant optic atrophy.
Science advancesDiagnostic and Imaging Features of Leber Hereditary Optic Neuropathy: An Individual Participant Data Meta-Analysis.
AJNR. American journal of neuroradiologyOptic neuropathy arising from the synergy between YARS2 and mitochondrial COX1 mutations.
Journal of genetics and genomics = Yi chuan xue baoMolecular Mechanism of Mitochondrial Complex I Disruption by m.14484T>C Underlying Leber Hereditary Optic Neuropathy.
bioRxiv : the preprint server for biologyPharmacological Depletion of Retinal Mononuclear Phagocytes Is Neuroprotective in a Mouse Model of Mitochondrial Optic Neuropathy.
Investigative ophthalmology & visual scienceOxidative Stress and Inflammatory Biomarkers in Aqueous Humor and Blood of Patients with Leber's Hereditary Optic Neuropathy.
Antioxidants (Basel, Switzerland)Leber Hereditary Optic Neuropathy-Associated Novel Mutation in MT-RNR2 Gene: A Case Report.
Case reports in ophthalmologyDifference in pupillary response to red and blue color stimuli between glaucoma and Leber hereditary optic neuropathy patients with comparable central visual dysfunction.
Documenta ophthalmologica. Advances in ophthalmologyAmyotrophic Lateral Sclerosis With Concurrent LHON-associated m.14484T>C Mutation: A Case Report and Literature Review.
Revista de neurologiaComparison of thickness changes in retinal nerve fibre layer in Leber's hereditary optic neuropathy patients with 11778, 14484 and 3460 mutations.
Translational pediatricsAtypical clinical and MRI features in Leber hereditary optic neuropathy: a case series of four patients.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical NeurophysiologyMaternal lineage diversity and health-related haplogroups in the Gilgiti and Kohistani populations of northern Pakistan.
BMC genomicsMitochondrial-Immune Overlap in Leber Hereditary Optic Neuropathy: A Case Report and Lessons Learned.
Reports (MDPI)Another One: A Novel Variant Associated With Leber Hereditary Optic Neuropathy.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology SocietyDifferentiating Leber's Hereditary Optic Neuropathy from Optic Neuritis in a Clinical Setting.
Annals of Indian Academy of NeurologyOptic Atrophy Predominant WFS1 Disorder-A Case-Control Study.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology SocietySerum neuronal, glial and mitochondrial markers in autosomal dominant optic atrophy and Leber hereditary optic neuropathy.
Brain communicationsMitochondria-targeted gene delivery using fluorinated lipid nanoparticles to alleviate Leber's hereditary optic neuropathy.
Nature communicationsTrans-generational maintenance of mitochondrial DNA integrity in oocytes during early folliculogenesis.
PLoS geneticsAdvanced therapies for inherited optic neuropathies.
Eye (London, England)Preclinical Assessment of Mitochondrial-Targeted ND4 Gene Therapy for Leber Hereditary Optic Neuropathy.
Investigative ophthalmology & visual scienceMetformin promotes mitochondrial integrity through AMPK-signaling in Leber's hereditary optic neuropathy.
FEBS open bioIn vivo mitochondrial base editing restores genotype and visual function in a mouse model of LHON.
Nature communications[Pathogenic mechanisms of Leber hereditary optic neuropathy caused by m.3472T>C mutation].
Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciencesThe Pedigree Study of Leber's Hereditary Optic Neuropathy in Korean Population.
Seminars in ophthalmologyRecessive variants in mitochondrial Complex I nuclear subunits are an underrated cause of optic atrophy.
Brain : a journal of neurologyFrom Castro to Quantum Mechanics: Marching Through Tunnels With Reactive Oxygen Species.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology SocietySuper mitochondria-enriched extracellular vesicles enable enhanced mitochondria transfer.
Nature communicationsNavigating Health When Sudden Blindness Occurs: The Experience of Leber Hereditary Optic Neuropathy.
Creative nursingDevelopment of Two In Vitro ND1-LHON Models for Evaluating Gene Therapy Efficacy.
Investigative ophthalmology & visual scienceChromatic pupil campimetry as objective diagnostic tool for progressive optic neuropathies.
Documenta ophthalmologica. Advances in ophthalmologyExploring rare mitochondrial DNA in Leber hereditary optic neuropathy.
Advances in ophthalmology practice and researchVisual Recovery in Leber's Hereditary Optic Neuropathy Plus: A Case Report and Literature Insight.
Case reports in ophthalmologyEfficacy and safety of intravitreal rAAV2-ND4 therapy for Leber's hereditary optic neuropathy.
Eye (London, England)Establishment of human Leber's hereditary optic neuropathy model using iPSC-derived retinal organoids.
Frontiers in cellular neuroscienceFirst Case in Lithuania of an Autosomal Recessive Mutation in the DNAJC30 Gene as a Cause of Leber's Hereditary Optic Neuropathy.
GenesClinical Features of Leber Hereditary Optic Neuropathy Carrying a Rare m.13051G>A Mitochondrial Mutation: A Case Report.
Korean journal of ophthalmology : KJOAge-Associated Differences in Optic Disc Findings of Leber's Hereditary Optic Neuropathy.
Neuro-ophthalmology (Aeolus Press)A Case of Late-Onset Leber's Hereditary Optic Neuropathy in Association with Heteroplasmic m.11778G>A/ND4 Mutation.
Neuro-ophthalmology (Aeolus Press)Clinical Research for Inherited Retinal Disease Related Pediatric Blindness: A Preliminary Descriptive Analysis Based on ClinicalTrials.gov.
Journal of multidisciplinary healthcareInfographic: therapeutic benefit of idebenone in patients with Leber hereditary optic neuropathy: the LEROS nonrandomized controlled trial.
Eye (London, England)Whole mitochondrial genome sequencing in individuals with Leber hereditary optic neuropathy negative for the common pathogenic mitochondrial DNA variants.
Frontiers in neurologyRasch analysis of the NEI-VFQ-25: vision-related quality of life in Leber hereditary optic neuropathy after lenadogene nolparvovec gene therapy.
BMJ open ophthalmologyOutcomes of idebenone therapy for Leber hereditary optic neuropathy in a cohort of patients from Wales.
Eye (London, England)An Additional Case of Leber Hereditary Optic Neuropathy With G9804A Mutation.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology SocietyStructural insights into DdCBE in action enable high-precision mitochondrial DNA editing.
Molecular cellEstradiol alleviates disease phenotypes caused by m.3635G > A mutation by activating mitochondrial biogenesis and PINK1-Parkin mediated mitophagy in iPSC-derived retinal pigment epithelium cells.
Cellular signallingMetabOCT: a clinical trial looking for a metabolomic signature predicting the onset of Leber's hereditary optic neuropathy in healthy MtDNA mutations carriers.
Metabolomics : Official journal of the Metabolomic SocietyQuantitative assessment of retinal microvasculature using optical coherence tomography angiography and correlation with visual acuity in leber's hereditary optic neuropathy.
International ophthalmologyMetformin may alter the course of Leber's hereditary optic neuropathy: a case report.
Frontiers in medicineLate-onset Leber's hereditary optic neuropathy and antiandrogens for prostate cancer: is there a causative link?
Frontiers in neurologyDeveloping Intravenous Delivery of Water-Soluble Prodrugs of Idebenone for the Treatment of Acute Ischemic Stroke.
ACS chemical neuroscienceEvaluation of Visual and Optical Coherence Tomography Outcomes in Patients with Leber's Hereditary Optic Neuropathy Treated with Idebenone.
Life (Basel, Switzerland)Combination treatment with antioxidants and creatine alleviates common and variant-specific mitochondrial impairments in Leber's hereditary optic neuropathy patient-derived fibroblasts.
Human molecular geneticsAnterograde degeneration along the visual pathway following optic nerve injury: a review.
Frontiers in neurologyInfographic: Efficacy and safety of intravitreal gene therapy for Leber hereditary optic neuropathy treated within 6 months of disease onset (RESCUE Trial).
Eye (London, England)In Vivo Reprogramming Dysfunctional Retinal Ganglion Cells and Visual-phototransduction via Wireless Charging Nanogold for Leber's Hereditary Optic Neuropathy.
Advanced materials (Deerfield Beach, Fla.)Initial Macular Ganglion Cell Changes During Conversion of Leber Hereditary Optic Neuropathy.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology SocietyExtraocular features of Leber hereditary optic neuropathy: A scoping review.
Journal of biological methodsTechnological advances in the diagnosis and management of inherited optic neuropathies.
Frontiers in neurology"Adrift From the World": Exploring the Lived Experiences of Individuals Affected by an Inherited Optic Neuropathy in the United Kingdom-A Qualitative Study.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes ResearchLeber Hereditary Optic Neuropathy and Epilepsy in a Mexican Patient.
CureusAcute Bilateral Vision Loss in a Young Male: A Case of Leber's Hereditary Optic Neuropathy.
CureusUncovering the Characteristics of Pupil Cycle Time (PCT) in Neuropathies and Retinopathies.
Vision (Basel, Switzerland)Large language models in neuro-ophthalmology diseases: ChatGPT vs Bard vs Bing.
International journal of ophthalmologyInfographic: landmark trials in neuro-ophthalmology - results of the REVERSE trial for unilateral gene therapy rAAV2/2-ND4 in leber hereditary optic neuropathy.
Eye (London, England)Predictors of Final Visual Outcome in Patients With Leber Hereditary Optic Neuropathy Treated With Lenadogene Nolparvovec Gene Therapy.
Investigative ophthalmology & visual scienceLeber's Hereditary Optic Neuropathy.
Medical archives (Sarajevo, Bosnia and Herzegovina)Therapeutic benefit of idebenone in Leber hereditary optic neuropathy: a systematic review and meta-analysis.
Ophthalmic geneticsThe Role of Estrogen in Mitochondrial Disease.
Cellular and molecular neurobiologyLeber's hereditary optic neuropathy-associated ND1 3733G>C mutation ameliorates the mitochondrial quality control and cellular homeostasis.
The Journal of biological chemistryClinical Characteristics of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis in Carriers of a Leber Hereditary Optic Neuropathy Variant.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology SocietyOptic nerve MRI findings in Leber's hereditary optic neuropathy.
Japanese journal of ophthalmologyAntioxidant therapy in inborn metabolic diseases.
Molecular genetics and metabolismEarly-Onset Hearing Loss in Leber's Hereditary Optic Neuropathy: A Case Report.
Ear, nose, & throat journalNitric Oxide May Adversely Affect the Metabolism and Viability of Retinal Organoids Derived from Patients with Leber Hereditary Optic Neuropathy.
The American journal of pathologyExploring the Phenotypic Heterogeneity and Bioenergetic Profile of the m.13513G>A mtDNA Substitution: A Heteroplasmy Perspective.
International journal of molecular sciencesThe crossroads of Leber hereditary optic neuropathy and autosomal dominant optic Atrophy: Clinical profiles of patients with coexisting pathogenic genetic variants.
American journal of ophthalmology case reportsBezafibrate was unsuccessful to treat leber hereditary optic neuropathy.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie[Mechanism of BNIP3-mediated mitophagy in m.3635G>A related Leber hereditary optic neuropathy].
Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical geneticsModifier variants in metabolic pathways are associated with an increased penetrance of Leber's Hereditary Optic Neuropathy.
European journal of human genetics : EJHGSARM1 loss protects retinal ganglion cells in a mouse model of autosomal dominant optic atrophy.
The Journal of clinical investigationRecurrent Optic Neuritis as a Misleading Presentation of Leber Hereditary Optic Neuropathy: The Need for High Clinical Suspicion in Young Men.
CureusLeber hereditary optic neuropathy: utilities and carer burden from British and Irish participants.
Orphanet journal of rare diseasesIsolated and Syndromic Genetic Optic Neuropathies: A Review of Genetic and Phenotypic Heterogeneity.
International journal of molecular sciencesIdebenone vs. rAAV2-ND4 gene therapy in the treatment of Leber's hereditary optic neuropathy: An indirect comparison meta-analysis.
Indian journal of ophthalmologyLeber hereditary optic neuropathy with the homoplasmic m.14484 T > C mutation presenting initially with cerebellar ataxia.
Journal of neurologyLeber Hereditary Optic Neuropathy With Magnetic Resonance Imaging Findings Suggestive of Optic Perineuritis and Optic Neuritis: A Diagnostic Challenge.
CureusCentral Vestibular Syndrome in Leber Hereditary Optic Neuropathy "Plus".
NeuropediatricsNovel in vivo models of autosomal optic atrophy reveal conserved pathological changes in neuronal mitochondrial structure and function.
FASEB journal : official publication of the Federation of American Societies for Experimental BiologyIncidence and health burden of 20 rare neurological diseases in South China from 2016 to 2022: a hospital-based observational study.
Orphanet journal of rare diseasesAlterations in ganglion cell and nerve fiber layer in Leber hereditary optic neuropathy across clinical stages.
BMC ophthalmologyAdult-Onset Bilateral Optic Neuropathy in a Patient with Non-Familial Childhood-Onset Generalized Dystonia Associated with Mitochondrial DNA 14459G>A Mutation: A Case Report and Review of Literature.
Neuro-ophthalmology (Aeolus Press)DNAJC30 Mutation in a Patient with Coexisting Leber's Hereditary Optic Neuropathy and Multiple Sclerosis (Harding's Syndrome): A Case Report.
Case reports in ophthalmologyCommunicating Hope and Fact to Families With Leber Hereditary Optic Neuropathy.
Clinical & experimental ophthalmologyMitochondrial DNA Pathogenic Variants in Ophthalmic Diseases: A Review.
GenesEarly Macular Ganglion Cell Loss in Leber Hereditary Optic Neuropathy, an Optical Coherence Tomography Biomarker to Differentiate Optic Neuritis.
Journal of clinical medicine[Evaluation of retinal microvascular characteristics in Leber hereditary optic neuropathy based on optical coherence tomography angiography].
Zhonghua yi xue za zhiLeber hereditary optic neuropathy in a family with two primary pathogenic variants: Report of a pedigree and review of the literature.
Journal francais d'ophtalmologiePeripapillary hyperreflective ovoid mass-like structure (PHOMS) and optic disc drusen in pediatric pseudo-papilledema.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle OphthalmologieRemarkable visual improvement in Leber hereditary optic neuropathy.
Japanese journal of ophthalmologyLeber's Hereditary Optic Neuropathy with Retinal Hemorrhage.
Neuro-ophthalmology (Aeolus Press)Leber's hereditary optic neuropathy and multiple sclerosis: overlap between mitochondrial disease and neuroinflammation.
Frontiers in neurologyVitamin A treatment restores vision failures arising from Leber's hereditary optic neuropathy-linked mtDNA mutation.
JCI insightResearch progress on paternal mitochondrial inheritance: An overview.
MitochondrionThe rAAV2-ND1 gene therapy for Leber hereditary optic neuropathy.
Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle OphthalmologieLeber Hereditary Optic Neuropathy "Plus" with the m.14487 T>C Mutation as the Causality of Hemidystonia: A Case Report.
Case reports in ophthalmologyLeber's hereditary optic neuropathy - current status of idebenone and gene replacement therapies.
Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.VFrequency and Pattern of Gene Therapy Clinical Trials for Inherited Retinal Diseases.
Advances in experimental medicine and biologyAn exploratory study to evaluate efficacy and safety of frequent Transcutaneous Electrical Stimulation for Leber Hereditary Optic Neuropathy.
Scientific reportsClinical spectrum, treatment and outcomes of the m.10197G>A mutation in MT-ND3: a case report, systematic review and meta-analysis.
Orphanet journal of rare diseasesA Case of Leber's Hereditary Optic Neuropathy With Reversible Symmetric Lesions in the Substantia Nigra.
CureusLeber Hereditary Optic Neuropathy: Support, Genetic Prediction and Accurate Genetic Counselling Enhance Family Planning Choices.
Clinical & experimental ophthalmologyCentral Serous Chorioretinopathy Associated with Corticosteroid Use in a Patient with Leber Hereditary Optic Neuropathy: A Case Report.
Medicina (Kaunas, Lithuania)Atypical Leber Hereditary Optic Neuropathy (LHON) Associated with a Novel MT-CYB:m.15309T>C(Ile188Thr) Variant.
GenesPrecise modelling of mitochondrial diseases using optimized mitoBEs.
NatureA bibliometric analysis of optic atrophy from 2003 to 2023: research trends and hot spots.
Frontiers in medicineFamily and genetic counseling in Leber hereditary optic neuropathy.
Ophthalmic geneticsNanoengineered mitochondria enable ocular mitochondrial disease therapy via the replacement of dysfunctional mitochondria.
Acta pharmaceutica Sinica. BClinical and Structural Parameters in Autosomal Dominant Optic Atrophy Patients: A Cross-Sectional Study Using Optical Coherence Tomography.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology SocietyIdebenone Protects Photoreceptors Impaired by Oxidative Phosphorylation Disorder in Retinal Detachment.
Investigative ophthalmology & visual scienceInsights on the Genetic and Phenotypic Complexities of Optic Neuropathies.
GenesVisual Functions in Patients With Leber Hereditary Optic Neuropathy.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology SocietyRisk Factors Associated With Leber Hereditary Optic Neuropathy due to Rare Mutations in Mitochondrial DNA-Encoded Respiratory Complex I Subunits.
Clinical geneticsReprogramming patient-induced pluripotent stem cell-specific retinal organoids for deciphering epigenetic modifications of RNA methylation.
Journal of the Chinese Medical Association : JCMAClinical trials in Leber hereditary optic neuropathy: outcomes and opportunities.
Current opinion in neurologySingle-Eye Gene Therapy for Leber Hereditary Optic Neuropathy.
JAMA ophthalmologyFive-Year Outcomes of Lenadogene Nolparvovec Gene Therapy in Leber Hereditary Optic Neuropathy.
JAMA ophthalmologyOpa1 and MT-Nd6 mutations induce early mitochondrial changes in the retina and prelaminar optic nerve of hereditary optic neuropathy mouse models.
Brain communicationsLNC-ing Genetics in Mitochondrial Disease.
Non-coding RNAEfficacy of Intravitreal rAAV2-ND4 Injection in Treated Versus Fellow Eyes with Leber's Hereditary Optic Neuropathy: A Meta-Analysis.
Neuro-ophthalmology (Aeolus Press)Respiratory Chain Complex I Deficiency in Leber Hereditary Optic Neuropathy: Insights from Ophthalmologic and Molecular Investigations in Tunisia.
BMC genomics[Brain magnetic resonance imaging features in Leber's hereditary optic neuropathy].
Vestnik oftalmologiiOptic Neuropathy AFG3L2 Related in a Patient Affected by Congenital Stationary Night Blindness.
Case reports in ophthalmological medicineChildhood Blindness: A Rare Case of Leber Hereditary Optic Neuropathy in a 16-Year-Old Egyptian Patient.
CureusLeber Hereditary Optic Neuropathy With Significant Visual Recovery: An MT-ND6 Mutation in a Malay Patient.
CureusPhase 2b program with sonlicromanol in patients with mitochondrial disease due to m.3243A>G mutation.
Brain : a journal of neurologyLeber hereditary optic neuropathy with disc haemorrhage.
Eye (London, England)Recent advances in neuro-ophthalmology.
Indian journal of ophthalmologyClinical and genetic landscape of optic atrophy in 826 families: insights from 50 nuclear genes.
Brain : a journal of neurologyMeta-analysis of treatment outcomes for patients with m.11778G>A MT-ND4 Leber hereditary optic neuropathy.
Survey of ophthalmologyHypoxia-mediated rescue of retinal ganglion cells deficient in mitochondrial complex I is independent of the hypoxia-inducible factor pathway.
Scientific reportsMonoallelic de novo variants in DDX17 cause a neurodevelopmental disorder.
Brain : a journal of neurologyAn Unusual Presentation of Leber Hereditary Optic Neuropathy-Plus Case Caused by a Novel DNAJC30 Variant.
American journal of medical genetics. Part AGanglion Cell Complex Thickness and Visual Function in Chronic Leber Hereditary Optic Neuropathy.
Investigative ophthalmology & visual scienceRecognizing Leber's Hereditary Optic Neuropathy to avoid delayed diagnosis and misdiagnosis.
Frontiers in neurologyPreservation of Mitochondrial Function by SkQ1 in Skin Fibroblasts Derived from Patients with Leber's Hereditary Optic Neuropathy Is Associated with the PINK1/PRKN-Mediated Mitophagy.
BiomedicinesRetinal damage promotes mitochondrial transfer in the visual system of a mouse model of Leber hereditary optic neuropathy.
Neurobiology of diseasePrimary mitochondrial diseases.
Handbook of clinical neurologyA transmitochondrial sodium gradient controls membrane potential in mammalian mitochondria.
CellDiagnostic dilemma: Leber's hereditary optic neuropathy in a 70-year-Old woman.
American journal of ophthalmology case reportsOcular genetics in the Japanese population.
Japanese journal of ophthalmologyMitochondrial tRNAGlu 14693A > G Mutation, an "Enhancer" to the Phenotypic Expression of Leber's Hereditary Optic Neuropathy.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)Leber hereditary optic neuropathy in Slovenia: quality of life and costs from patient perspective.
Orphanet journal of rare diseasesDefective post-transcriptional modification of tRNA disrupts mitochondrial homeostasis in Leber's hereditary optic neuropathy.
The Journal of biological chemistryMitochondria in Retinal Ganglion Cells: Unraveling the Metabolic Nexus and Oxidative Stress.
International journal of molecular sciencesMetabolic Deficits in the Retina of a Familial Dysautonomia Mouse Model.
MetabolitesClinical follow-up investigation on thickness changes in the peripapillary retinal nerve fibre layer of patients with Leber hereditary optic neuropathy.
BMC ophthalmologyDysregulation of mitochondria, apoptosis and mitophagy in Leber's hereditary optic neuropathy with MT-ND1 3635G>A mutation.
GeneMSC-mediated mitochondrial transfer restores mitochondrial DNA and function in neural progenitor cells of Leber's hereditary optic neuropathy.
Science China. Life sciencesInhibition of angiogenesis by the secretome from iPSC-derived retinal ganglion cells with Leber's hereditary optic neuropathy-like phenotypes.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapieEndocrine Disorders in Children with Primary Mitochondrial Diseases: Single Center Experience.
Journal of clinical research in pediatric endocrinologyA Comprehensive Review of Leber Hereditary Optic Neuropathy and Its Association with Multiple Sclerosis-Like Phenotypes Known as Harding's Disease.
Eye and brainFamily Planning in Genetic Optic Atrophies in Israel, a Case Series and a Discussion of Ethical Considerations.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology SocietyLeber Hereditary Optic Neuropathy Case Report: Clinical Presentation and Treatment with Idebenone Reinforce the Evidence for m.3866T>C as a Causative Variant.
Case reports in ophthalmologyExtranuclear DNA Variations in the Susceptibility of Glaucoma.
Middle East African journal of ophthalmologyExtensive Optic Tracts Involvement in the Acute Phase of Leber Hereditary Optic Neuropathy.
NeurologyA case for the use of chemotherapy in hereditary mitochondrial optic neuropathies: Successful administration of cisplatin/etoposide in a male patient with testicular seminoma and Leber's hereditary optic neuropathy.
Clinical case reportsAssessment of objective visual function following idebenone administration in patients with leber hereditary optic neuropathy.
Japanese journal of ophthalmologyLeber hereditary optic neuropathy in Czechia and Slovakia: Quality of life and costs from patient perspective.
HeliyonGene therapy for Leber hereditary optic neuropathy.
Expert opinion on biological therapyOptic Nerve T2 Signal Intensity and Caliber Reflect Clinical Severity in Genetic Optic Atrophy.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology SocietyA computational study to assess the pathogenicity of single or combinations of missense variants on respiratory complex I.
International journal of biological macromoleculesElectrodiagnostic tests of the visual pathway and applications in neuro-ophthalmology.
Eye (London, England)Maculopapillary Bundle Degeneration in Optic Neuropathies.
Current neurology and neuroscience reportsPrevalence of Leber hereditary optic neuropathy in the Community of Madrid (Spain), estimation with a capture-recapture method.
Orphanet journal of rare diseasesGenetic susceptibility to optic neuropathy in patients with alcohol use disorder.
Journal of translational medicineImpaired mitochondrial morphological plasticity and failure of mitophagy associated with the G11778A mutation of LHON.
Biochemical and biophysical research communicationsCo-occurrence of glial fibrillary acidic protein astrocytopathy in a patient with Leber's hereditary optic neuropathy due to DNAJC30 mutations.
European journal of neurologyLeber's hereditary optic neuropathy like disease in MT-ATP6 variant m.8969G>A.
American journal of ophthalmology case reportsDeep Brain Stimulation for Medication Refractory Tremor in Leber Optic Neuropathy Plus Syndrome.
CureusNovel Mutations in the ND5 Gene Associated With Leber Hereditary Optic Neuropathy.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology SocietyAtypical Late-Onset Leber Hereditary Optic Neuropathy (LHON) Associated With T14484C Mutation.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology SocietyAutosomal recessive leber hereditary optic neuropathy in a choroideremia carrier. A case report.
European journal of ophthalmologyGalactose-replacement unmasks the biochemical consequences of the G11778A mitochondrial DNA mutation of LHON in patient-derived fibroblasts.
Experimental cell researchPreserved Ganglion Cell Analysis in a Case of Longstanding Leber Hereditary Optic Neuropathy: A Sign of Hibernating Neurons?
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society[Leber's hereditary optic neuropathy].
Rinsho shinkeigaku = Clinical neurologyAssociações
Organizações que acompanham esta doença — pra ter apoio e orientação
Ainda não temos associações cadastradas para Neuropatia óptica hereditária.
É de uma associação que acompanha esta doença? Fale com a gente →
Comunidades
Grupos ativos de quem convive com esta doença aqui no Raras
Ainda não existe comunidade no Raras para Neuropatia óptica hereditária
Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.
Tire suas dúvidas
Perguntas, dicas e experiências compartilhadas aqui na página
Participe da discussão
Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.
Fazer loginDoenças relacionadas
Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico
Referências e fontes
Bases de dados externas citadas neste artigo
Publicações científicas
Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.
- Disrupted energy metabolism is associated with retinal ganglion cell degeneration in autosomal dominant optic atrophy.
- Pharmacological Depletion of Retinal Mononuclear Phagocytes Is Neuroprotective in a Mouse Model of Mitochondrial Optic Neuropathy.
- Atypical clinical and MRI features in Leber hereditary optic neuropathy: a case series of four patients.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology· 2026· PMID 41483035mais citado
- Modifier variants in metabolic pathways are associated with an increased penetrance of Leber's Hereditary Optic Neuropathy.
- A multistage cost-effective strategy for the molecular diagnosis of unexplained vision loss patients: practice in inherited ocular fundus disease.
- Leber Hereditary Optic Neuropathy in the Elderly: A Case Report.
- Optimized ND4 allotopic expression for gene therapy of Leber's hereditary optic neuropathy.
- Leber hereditary optic neuropathy triggered by the AstraZeneca coronavirus disease 2019 vaccination.
- Impact of individualized colored spectacle filters on photophobia and visual comfort in central visual field defect patients: a one-year study.
- Chronic Progressive External Ophthalmoplegia Associated With the m.14484T>C Leber Hereditary Optic Neuropathy Mutation.
Bases de dados e fontes oficiais
Identificadores e referências canônicas usadas para montar este verbete.
- ORPHA:98671(Orphanet)
- MONDO:0020249(MONDO)
- GARD:19540(GARD (NIH))
- Variantes catalogadas(ClinVar)
- Busca completa no PubMed(PubMed)
- Q55789244(Wikidata)
Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.
Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar
